were processed using HKL2000 3 in the same space group with cell dimensions of a = 27.6 Å, b = 41.3 Å and c = 56.8 Å. Molecular replacement in Phaser 4 using 1cka as the search model 5 could output a unique solution in the same space group with one copy of the protein in the asymmetric unit. The solution was subjected to an initial cycle of model building using AutoBuild module of PHENIX 6 following which several iterations of manual model building in COOT 7 and refinement in REFMAC 8 were carried out. PRM-2 was added to the model guided by the Fo-Fc map. Water molecules were added after one more round of real and reciprocal space refinement. The final structure has R/R free = 17%/21%. The electrostatic potential surface of nSH3 domain was calculated using APBS and PDB2PQR. [9] [10] [11] NMR spectroscopy: NMR HSQC spectrum was acquired using a protein sample in 20 mM sodium phosphate (pH 6.1), 80 mM NaCl, 0.02% sodium azide, 1 mM EDTA, 10 μM DSS (4,4-dimethyl-4-silapentane-sulfonate), and 10% D 2 O at 25 C. The NMR experiment was performed on Bruker Avance 600 MHz spectrometers equipped with a cryogenic probe. NMR spectra were processed with NMRPipe 12 and analyzed with NMRViewJ (One Moon Scientific, Inc.). The temperatures of NMR sample were calibrated using the deuterated methanol-d 4 
where F and F max are the change and the maximum amplitude of signal change, respectively. P t is the total protein concentration and L t is the total ligand concentration at each titration point. 
the data. The uncertainty of the G bind (298 K) was estimated by 95% confidence intervals of the linear regression curve.
CRK-phosphorylation assay: 2 M of CRK-II (residues 1 -304) was incubated with 5 nM recombinant human wild type ABL kinase (ProQinase, residues 118 -535) in 20 m M Tris (pH 7.6), 50mM NaCl, 2 mM DTT, 2 mM MgCl 2 , 100 M ATP at 25 C. The reaction conditions for T315I ABL kinase were the same except that the concentration of T315I ABL kinase was 25 nM.
The specific activity of T315I ABL was 10-fold lower than that of wild type ABL. The phosphorylation reaction was stopped by adding 15 mM EDTA. The phosphorylated and nonphosphorylated CRK-II were separated by running a native polyacrylamide gel electrophoresis (12%). Thermo Scientific Pierce Silver Statin kit was used for detection of protein bands. The band intensity was measured by ImageJ. 14 It should also be noted that the inhibitory activity of PRM-3 depends on the concentration of CRK-II used in the assay since PRM-3 binds to CRK-II, which is a substrate of ABL kinase. This rules out using IC 50 as an indicator for inhibitor activity because the IC 50 value changes depending on the concentration of CRK-II used in the in vitro assay. Instead, comparison with imatinib provides an alternative way to assess the inhibitory activity of PRM-3 on ABL-dependent CRK phosphorylation. 8 Figure S4 . Figure S4 . Time-dependent phosphorylation of CRK-II using (A) wild type and (B) T315I ABL kinase in the absence (control) and presence of PRM-3 or imatinib. The minor band below a major band is not an impurity but an alternative conformation separated during native PAGE. CRK-II undergoes structural exchange between alternative conformations. 16 The reported phosphorylation ratio is the average and standard deviation of four repeated assays.
